-transparent.png){kind=logo}
A selective antagonist of S2-serotonergic receptors, ketanserin, was administered intravenously during right heart catheterization to 14 patients with pulmonary hypertension complicating systemic sclerosis. A significant reduction in pulmonary vascular resistance was noted which was accompanied by an increase in cardiac output. Paradoxical increase of pulmonary artery pressure occurred in 3 patients, whereas 2 patients with mild pulmonary hypertension normalized both pulmonary pressure and vascular resistance. Our data support the hypothesis that serotonin, released during in vivo platelet activation, influences pulmonary vascular tone in systemic sclerosis.
Related Publications
J R Seibold, and
R R Molony, and
D Turkevich, and
M C Ruddy, and
J B Kostis
March 1998,
Arthritis and rheumatism,
J R Seibold, and
R R Molony, and
D Turkevich, and
M C Ruddy, and
J B Kostis
October 2000,
Chest,
J R Seibold, and
R R Molony, and
D Turkevich, and
M C Ruddy, and
J B Kostis
January 1987,
Acta cardiologica,
J R Seibold, and
R R Molony, and
D Turkevich, and
M C Ruddy, and
J B Kostis
February 1999,
Respiratory medicine,
J R Seibold, and
R R Molony, and
D Turkevich, and
M C Ruddy, and
J B Kostis
June 2024,
Cardiovascular drugs and therapy,
J R Seibold, and
R R Molony, and
D Turkevich, and
M C Ruddy, and
J B Kostis
January 2019,
Pulmonary circulation,
J R Seibold, and
R R Molony, and
D Turkevich, and
M C Ruddy, and
J B Kostis
January 1987,
Journal of cardiovascular pharmacology,
J R Seibold, and
R R Molony, and
D Turkevich, and
M C Ruddy, and
J B Kostis
March 1987,
International journal of cardiology,
J R Seibold, and
R R Molony, and
D Turkevich, and
M C Ruddy, and
J B Kostis
January 2023,
Cardiovascular drugs and therapy,
J R Seibold, and
R R Molony, and
D Turkevich, and
M C Ruddy, and
J B Kostis
July 1983,
Annals of internal medicine,
